![Ole Dahlberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ole Dahlberg
Gründer bei
Qvint Biotech AS
Vermögen: 33 952 $ am 31.08.2026
Profil
Ole Jesper Dahlberg is the founder of Cytomics Pharmaceuticals SA, founded in 2000.
Mr. Dahlberg is also the founder of Qvint Biotech AS.
Current jobs include Chairman at Nadeno Nanoscience AS since 2023 and Chairman at Curida.
AS since 2022.
Former jobs include Chief Executive Officer at Mole Genetics AS, Director at Medistim ASA, Senior Scientist at Orchid Cellmark, Inc., and Vice President-Sales at Qiagen, Inc. Education includes a graduate degree from the University of Oslo, conferred in 1997.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MEDISTIM ASA 0,01 % | 31.12.2024 | 1.240 ( 0,01 % ) | 33 952 $ | 31.08.2026 |
Aktive Positionen von Ole Dahlberg
| Unternehmen | Position | Beginn |
|---|---|---|
Qvint Biotech AS | Gründer | 23.07.2009 |
Nadeno Nanoscience AS
 Nadeno Nanoscience AS BiotechnologyHealth Technology Provides research on nanotechnology drug delivery platform | Vorsitzender | 01.02.2023 |
Curida AS
 Curida AS Pharmaceuticals: MajorHealth Technology Manufactures and markets nasal and inhalation drug products | Vorsitzender | 01.02.2022 |
Ehemalige bekannte Positionen von Ole Dahlberg
| Unternehmen | Position | Ende |
|---|---|---|
| MEDISTIM ASA | Direktor/Vorstandsmitglied | 08.05.2025 |
Cytomics Pharmaceuticals SA
 Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules which controls protein turnover | Gründer | 10.10.2011 |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids | Vertrieb & Marketing | - |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Corporate Officer/Principal | - |
Mole Genetics AS
 Mole Genetics AS BiotechnologyHealth Technology Manufactures and sells instruments & pre-filled reagent cartridges for genetic research | Präsident | - |
Ausbildung von Ole Dahlberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Orchid Cellmark, Inc.
Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Medistim ASA
 Medistim ASA Medical SpecialtiesHealth Technology Develops, manufactures and distributes solutions for cardiac & vascular surgery | Health Technology |
Cytomics Pharmaceuticals SA
Cytomics Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules which controls protein turnover | Health Technology |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides technologies for separating, purifying and handling nucleic acids | Commercial Services |
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Manufactures and sells instruments & pre-filled reagent cartridges for genetic research | Health Technology |
Qvint Biotech AS | |
Curida AS
Curida AS Pharmaceuticals: MajorHealth Technology Manufactures and markets nasal and inhalation drug products | Health Technology |
Nadeno Nanoscience AS
Nadeno Nanoscience AS BiotechnologyHealth Technology Provides research on nanotechnology drug delivery platform | Health Technology |
